Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Risk of all-cause mortality in HIV infected patients is associated with clinical, immunologic predictors and the CCR5 Δ32 deletion.

Parczewski M, Bander D, Leszczyszyn-Pynka M, Urbanska A, Kaczmarczyk M, Ciechanowicz A, Boron-Kaczmarska A.

PLoS One. 2011;6(7):e22215. doi: 10.1371/journal.pone.0022215. Epub 2011 Jul 18.

2.

HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion.

Sheppard HW, Celum C, Michael NL, O'Brien S, Dean M, Carrington M, Dondero D, Buchbinder SP.

J Acquir Immune Defic Syndr. 2002 Mar 1;29(3):307-13. Review.

PMID:
11873082
3.

The evolutionary history of the CCR5-Delta32 HIV-resistance mutation.

Galvani AP, Novembre J.

Microbes Infect. 2005 Feb;7(2):302-9. Epub 2005 Jan 8. Review.

PMID:
15715976
4.
5.

A review of the study designs and statistical methods used in the determination of predictors of all-cause mortality in HIV-infected cohorts: 2002-2011.

Otwombe KN, Petzold M, Martinson N, Chirwa T.

PLoS One. 2014 Feb 3;9(2):e87356. doi: 10.1371/journal.pone.0087356. eCollection 2014. Review.

6.

Genome editing-based HIV therapies.

Gu WG.

Trends Biotechnol. 2015 Mar;33(3):172-9. doi: 10.1016/j.tibtech.2014.12.006. Epub 2015 Jan 15. Review.

PMID:
25600622

Supplemental Content

Support Center